SimplyTest® has signed a partnership agreement with Evexia Diagnostics, a leading provider of diagnostic laboratory services for unified and functional medicine. With this partnership deal, the two SimplyTests’ focused examinations, 4-point cortisol and SimplyTest PERIO, are now available via Evexia’s robust ordering platform. The platform that encourages healthcare practitioners to use new tools for data-proved, personalised care.
Since 2007, Evexia Diagnostics has delivered to non-licensed and licensed practitioners by providing a cash-based portfolio that combines a number of conventional tests and specialities. This collaboration is a valuable and important step in introducing SimplyTest’s solutions to a vast number of clinicians looking for an affordable, efficient diagnostic alternative without the stress of traditional insurance models.
The CEO of SimplyTest, Damon Silvestry, said, “We’re excited to partner with Evexia Diagnostics in our joint mission to present clinical testing as a more suitable, practitioner-friendly and accessible option. Our Cortisol and PERIO tests are strong tools for notifying major contributors to stress-related dysfunction and chronic inflammation. Following this, Evexia’s platform is the perfect place to make them accessible to the functional medicine society.”
The SimplyTest PERIO test helps to address periodontal pathogens aligned to chronic disease and systemic inflammation. This contributed to the whole-body health initiative and early intervention to avoid an extreme scenario. The 4-Point Cortisol test is an examination structure for non-invasive salivary cortisol that measures biologically active free cortisol at four points in a day to analyse HPA axis function and diurnal rhythm.
These capabilities help practitioners to get valuable insights considering major factors that need to reach to the healthcare community and patients at the right time. This partnership will integrate access, stand as a strong support for licensed and non-licensed providers. Alongside the clinical insight tools, the tests can be consolidated with Evexia’s “Ask the Doctor” and Functional Health Report services for a super clinical context.
The Chief Commercial Officer at Evexia Diagnostics, Ryan Obermeier, said, “Evexia is always seeking expansionary growth to make tools accessible to clinicians who encourage preventive, integrative and precision care. SimplyTest’s 4-Point and Perio Cortisol panels harness our previous catalogue ideally. This gives practitioners access to two clinically suitable tests that will help them address imbalance, underlying risk and enhance the patient outcomes.”
Mansi Kadam is a market research writer with over 3 years of experience analyzing trends in the healthcare industry. At Towards Healthcare, she covers innovations in medical sector, sustainability initiatives, and the evolving regulatory landscape.
